These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32236736)

  • 1. PTEN activation contributes to neuronal and synaptic engulfment by microglia in tauopathy.
    Benetatos J; Bennett RE; Evans HT; Ellis SA; Hyman BT; Bodea LG; Götz J
    Acta Neuropathol; 2020 Jul; 140(1):7-24. PubMed ID: 32236736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intersection of pathological tau and microglia at the synapse.
    Vogels T; Murgoci AN; Hromádka T
    Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic alterations in the rTg4510 mouse model of tauopathy.
    Kopeikina KJ; Polydoro M; Tai HC; Yaeger E; Carlson GA; Pitstick R; Hyman BT; Spires-Jones TL
    J Comp Neurol; 2013 Apr; 521(6):1334-53. PubMed ID: 23047530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy.
    Sahara N; Maeda J; Ishikawa A; Tokunaga M; Suhara T; Higuchi M
    J Alzheimers Dis; 2018; 64(s1):S353-S359. PubMed ID: 29865054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.
    Carvalho K; Faivre E; Pietrowski MJ; Marques X; Gomez-Murcia V; Deleau A; Huin V; Hansen JN; Kozlov S; Danis C; Temido-Ferreira M; Coelho JE; Mériaux C; Eddarkaoui S; Gras SL; Dumoulin M; Cellai L; ; Landrieu I; Chern Y; Hamdane M; Buée L; Boutillier AL; Levi S; Halle A; Lopes LV; Blum D
    Brain; 2019 Nov; 142(11):3636-3654. PubMed ID: 31599329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia.
    Wang C; Xiong M; Gratuze M; Bao X; Shi Y; Andhey PS; Manis M; Schroeder C; Yin Z; Madore C; Butovsky O; Artyomov M; Ulrich JD; Holtzman DM
    Neuron; 2021 May; 109(10):1657-1674.e7. PubMed ID: 33831349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
    J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
    Dejanovic B; Huntley MA; De Mazière A; Meilandt WJ; Wu T; Srinivasan K; Jiang Z; Gandham V; Friedman BA; Ngu H; Foreman O; Carano RAD; Chih B; Klumperman J; Bakalarski C; Hanson JE; Sheng M
    Neuron; 2018 Dec; 100(6):1322-1336.e7. PubMed ID: 30392797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic Localisation of Tau.
    Hanger DP; Goniotaki D; Noble W
    Adv Exp Med Biol; 2019; 1184():105-112. PubMed ID: 32096032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy.
    Wang C; Fan L; Khawaja RR; Liu B; Zhan L; Kodama L; Chin M; Li Y; Le D; Zhou Y; Condello C; Grinberg LT; Seeley WW; Miller BL; Mok SA; Gestwicki JE; Cuervo AM; Luo W; Gan L
    Nat Commun; 2022 Apr; 13(1):1969. PubMed ID: 35413950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
    Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
    J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
    Vagnozzi AN; Giannopoulos PF; Praticò D
    Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
    Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
    Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
    Köhler C; Fuhr V; Dinekov M
    Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
    Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
    J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.